Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

On January 7, 2026 Emergent BioSolutions Inc. (NYSE: EBS) reported that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The audio link for Emergent’s session may be accessed here and will be live for up to 30 days.

The Company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website.

(Press release, Emergent BioSolutions, JAN 7, 2026, View Source [SID1234661798])